<DOC>
	<DOCNO>NCT02908360</DOCNO>
	<brief_summary>The prevalence allergic disease ( atopic dermatitis , asthma , rhinitis , conjunctivitis food allergy ) increase dramatically industrialized country last 20-30 year . Allergic diseases present especially child young adult , age group affect , variation across country age . To propose new therapy , investigator must first understand physiopathology . Since discovery regulatory T cell continue subject work understand role maintain immune homeostasis human body also involvement autoimmune disease , inflammatory disease , transplant solid organ fluid allergic disease . It identify two broad class regulatory T cell : - T cell = natural regulator acquisition phenotype regulatory function right thymus ( CD25 + / CD127 + low / FoxP3 + ) . - T cell induced regulator = acquisition phenotype regulatory function periphery depend cytokine micro-environment . Phenotypic characterization less obvious even last ten year several induce regulatory T cell population describe ( eg , Tr1 ) . A new subpopulation T cell induce patient inflammatory bowel disease recently identify particular phenotype bearing CD4 CD8 double mark regulatory phenotype . These regulatory T cell also induce specific commensal intestinal bacterium ( Faecalibacterium prausnitzii ) . Regarding allergy , widely demonstrate relationship change intestinal microbiota occurrence allergic disease . The investigator would therefore propose cross-sectional study , single-center , control , single blind study role T cell call double positive induced regulator DP8 compare frequency regulatory function specific DP8 Faecalibacterium prausnitzii atopic dermatitis , asthma allergic rhinitis compare control sample .</brief_summary>
	<brief_title>Study Frequency Regulatory Function Positive T Lymphocytes Dual CD4CD8aa ( DP8a ) Specific Bacteria Intestinal Microbiota ( Faecalibacterium Prausnitzii ) Atopic Dermatitis , Asthma Allergic Rhinitis</brief_title>
	<detailed_description>The primary endpoint highlight quantitative reduction double positive T cell ( CD4 + / CD8 + ) specific F prausnitzii peripheral blood patient allergic asthma , allergic rhinitis atopic dermatitis compare sample control sample collection make available laboratory BIOFORTIS® locate near Nantes University Nantes .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>non smoker BMI &lt; 30kg/m² No contraindication pricktest Inform consent sign genetics belong social security scheme patient allergic rhinitis atopic dermatitis allergic asthma major major incapable protect antimicrobial treatment ( antibiotic , antifungal antiviral ) contact MDR bacteria receive receive specific immunotherapy History cancer hematopoietic system antecedent acquire immune deficiency HIV congenital immunodeficiency inflammatory bowel disease autoimmune disease / inflammatory solid organ transplant hematopoietic cell addict pregnant childbearing age without effective contraception failure acute chronic severe organ hardly speak French / difficult understand French</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Double positive lymphocyte T F prausnitzii</keyword>
</DOC>